AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 112 min read$CROX

Rees Andrew sold $4.2M of CROX (indirect holdings)

Rees Andrew (Chief Executive Officer) sold 30,000 indirectly-held shares of Crocs, Inc. (CROX) at an average of $138.49 ($137.41–$140.02, $4.15M total) across 6 trades over 2026-08-07 to 2026-08-10.

Original reporting
SEC EDGAR · Rees Andrew
Published Aug 11, 2026, 3:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 11, 2026, 3:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CROX
Neutral
medium confidence
Mentioned
$CROX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CROXNeutralLow
01

Why it matters

The newest information is the specific open-market sale details (shares, dates, price range, and total value) disclosed in the filing. It may influence short-term sentiment but does not provide new operating or financial guidance.

02

Market read

Traders may briefly reassess CROX sentiment due to a CEO sale, but the disclosure lacks fundamental catalysts.

03

What to watch

Because the filing states indirect holdings and does not cite a 10b5-1 plan, traders may over-weight it; confirm whether other insiders filed contemporaneous transactions or whether there is a broader pattern.

Relevance 6/10Novelty 5/10Timing: filed 2026-08-11, after-hours/near close disclosure window

Background

The article is an SEC Form 4 insider transaction disclosure for Crocs, Inc. (CROX) by CEO Andrew Rees.

Company-level read

Ticker impact

$CROXNeutralMedium confidence
Context

Crocs CEO Andrew Rees sold about 30,000 shares in open-market trades for roughly $4.15M, per a new SEC Form 4 filed today.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-through only if additional filings or company-specific news appear.

Evidence & confidence

The filing provides transaction size, dates, and pricing range, but it does not include new earnings, guidance, or operational/regulatory developments. Insider sales can be interpreted as liquidity or diversification, and the absence of a stated 10b5-1 plan adds some uncertainty.

Market effects

Sector

Minimal; insider-sale filings rarely reset sector expectations without accompanying company fundamentals.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale may be routine liquidity or tax-related, and the disclosed price range suggests execution across multiple days rather than a single panic move.

Key entities

  • issuer
    Crocs, Inc.

    US-listed footwear company subject of the Form 4 insider transaction disclosure.

  • insider
    Andrew Rees

    Chief Executive Officer and director who sold shares via open-market transactions.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CROX insider trading history →

Related articles

OCT 2
$NKEMed

Nike’s Weak First Quarter Report Ripples Across Footwear Sector

Nike reported weaker-than-expected Q1 sales and announced layoffs, causing its shares to drop 6.6% to $32.84. Competitors like Adidas and Puma saw mixed reactions, while other footwear brands and retailers experienced varied share price movements. Retailers such as Academy Sports + Outdoors and Dick’s Sporting Goods saw gains.

wwd.com2 min
SEP 27
$CROXMedAI 8/10

Crocs sues Five Below, alleging they copied the famous clogs

Crocs and Jibbitz Charms sued Five Below, alleging trademark and patent infringement for selling clogs and charms resembling Crocs' products. The lawsuit seeks damages and a permanent injunction. Five Below's net sales rose 27% year-over-year to $344 million by August, with 101 new stores opened.

spokesman.com2 min
SEP 25
$CROXMed

Crocs Sues Five Below Over Alleged Knockoff Clogs and Charms

Crocs sued Five Below for allegedly infringing on its patents and trademarks with the sale of its Juniors Charm Clog. The lawsuit, filed in Colorado, claims Five Below's clogs and charms mimic Crocs' designs, misleading consumers. Crocs seeks damages, a permanent injunction, and destruction of infringing inventory. Five Below's clogs retail for $7, while Crocs' Kids Classic Clog sells for $39.99.

news.ssbcrack.com2 min
SEP 24
$CROXMed

Crocs and Five Below are in a legal fight over a $7 shoe

Crocs is suing Five Below, alleging that its clogs and charms infringe on Crocs' trademarks and patents. The lawsuit seeks damages, a halt to sales, and destruction of inventory. Five Below reported strong financial results, with net sales up 27% and net income over $344 million. Crocs generates over $4 billion in annual sales.

aol.com2 min
SEP 24
$CROXMedAI 8/10

Crocs sues Five Below, alleging they copied the famous clogs

Crocs has sued Five Below, alleging trademark and patent infringement by selling clogs and accessories resembling Crocs' products. The lawsuit, filed in Colorado, seeks damages and a permanent injunction. Five Below's net sales increased over 27% year-over-year, with net income of $344 million as of August, according to its earnings report.

inquirer.com2 min